That of the Eli Lilly’s daily pill for weight loss

The results of encourageing clinical trials announced Thursday are sitting down to open a huge market for a practical daily pill to treat obesity and diabetes.

The experimental medication, developed by Eli Lilly and known as Orforglipron, is a type of medication known as GLP-1. Drugs of this class like Wegovy have become extremely popular because they help people lose weight.

But these drugs must be given as weekly injections, which has limited their use. If Orforglipron can provide similar results in the form of an easy -to -take pill, as the study has suggested, it has the potential to reach many patients and become a major blockbuster.

Here is what you need to know about the Eli Lilly pill, which must always go through an examination process by the Food and Drug Administration to be approved for sale.

When will the pill be available?

Eli Lilly said he was planning to request regulatory approval to market the drug loss later this year, and early next year for diabetes. The F.DA. could take months and perhaps more time to examine the data of the company’s test before making a decision.

Wall Street analysts said that if everything was going well, or Forglipron could be available in the United States in the second half of next year.